Wells Fargo Portfolio holdings
Wells Fargo & Company, founded in 1852 by Henry Wells and William Fargo, is a major American financial institution headquartered in San Francisco, California, known for its extensive retail banking network and historical roots in the American West. Offering a wide range of services—including consumer banking, mortgages, wealth management, and commercial finance—it manages trillions in assets and serves millions of customers through thousands of branches and ATMs across the U.S. Despite its prominence, Wells Fargo faced significant scrutiny following a 2016 scandal involving millions of unauthorized accounts, leading to leadership changes and regulatory penalties, though it has since focused on rebuilding trust and enhancing digital banking capabilities. With a legacy tied to stagecoaches and a modern focus on diversified financial services, Wells Fargo remains a key player in the U.S. banking sector.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$771M |
| 2 |
Fidelity Enhanced Mid Cap Core ETF
FMDE
|
+$648M |
| 3 |
Amazon
AMZN
|
+$647M |
| 4 |
Mastercard
MA
|
+$636M |
| 5 |
Broadcom
AVGO
|
+$584M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$7.91B |
| 2 |
NVIDIA
NVDA
|
+$1.1B |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$663M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$624M |
| 5 |
Illinois Tool Works
ITW
|
+$520M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 46.69% |
| 2 | Technology | 15.08% |
| 3 | Financials | 7.45% |
| 4 | Industrials | 5.83% |
| 5 | Healthcare | 5.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
MSSM
6126
Morgan Stanley Pathway Small-Mid Cap Equity ETF
MSSM
$698M
| $1.29K | ﹤0.01% |
25
-54
| -68% | -$2.88K |
2024 Q4
5 quarters
|
|
6127
Crown Crafts
CRWS
$26.5M
| $1.29K | ﹤0.01% |
500
| – | – |
2013 Q2
51 quarters
|
|
6128
Turkcell
TKC
$4.51B
| $1.28K | ﹤0.01% |
213
-62
| -23% | -$394 |
2013 Q2
51 quarters
|
|
|
FARM
6129
DELISTED
Farmer Brothers
FARM
| $1.27K | ﹤0.01% |
1,000
| – | – |
2013 Q4
49 quarters
|
|
|
MDA
6130
MDA Space Ltd
MDA
$4.78B
| $1.26K | ﹤0.01% |
+50
| New | +$1.47K |
2026 Q1
0 quarters
|
|
6131
Direxion Auspice Broad Commodity Strategy ETF
COM
$211M
| $1.26K | ﹤0.01% |
37
+35
| +1,750% | +$1.11K |
2025 Q2
3 quarters
|
|
6132
Precipio
PRPO
$43M
| $1.25K | ﹤0.01% |
50
| – | – |
2019 Q1
28 quarters
|
|
6133
US Global Investors
GROW
$35.7M
| $1.24K | ﹤0.01% |
501
+1
| +0.2% | +$3 |
2013 Q2
51 quarters
|
|
6134
Heartbeam
BEAT
$36.9M
| $1.22K | ﹤0.01% |
1,000
| – | – |
2024 Q4
5 quarters
|
|
|
TMQ
6135
Trilogy Metals
TMQ
$551M
| $1.22K | ﹤0.01% |
339
-2,088
| -86% | -$9.53K |
2013 Q2
51 quarters
|
|
6136
Radcom
RDCM
$174M
| $1.22K | ﹤0.01% |
100
-300
| -75% | -$3.58K |
2020 Q1
24 quarters
|
|
6137
First Trust Core Investment Grade ETF
FTCB
$2.64B
| $1.21K | ﹤0.01% |
58
-43,852
| -100% | -$930K |
2025 Q2
3 quarters
|
|
6138
KVH Industries
KVHI
$126M
| $1.19K | ﹤0.01% |
133
| – | – |
2025 Q4
1 quarter
|
|
6139
Atara Biotherapeutics
ATRA
$94.4M
| $1.19K | ﹤0.01% |
251
| – | – |
2014 Q4
45 quarters
|
|
6140
Intensity Therapeutics
INTS
$11.3M
| $1.18K | ﹤0.01% |
+200
| New | +$1.63K |
2026 Q1
0 quarters
|
|
6141
Tiziana Life Sciences
TLSA
$136M
| $1.17K | ﹤0.01% |
1,000
-952
| -49% | -$1.35K |
2024 Q4
5 quarters
|
|
6142
Envoy Medical
COCH
$50.4M
| $1.16K | ﹤0.01% |
1,738
| – | – |
2023 Q4
9 quarters
|
|
|
NVNO
6143
enVVeno Medical
NVNO
$5.57M
| $1.16K | ﹤0.01% |
114
+57
| +100% | +$624 |
2020 Q1
24 quarters
|
|
6144
Guardforce AI
GFAI
$9.23M
| $1.12K | ﹤0.01% |
2,500
-42
| -2% | -$23 |
2025 Q1
4 quarters
|
|
6145
Hafnia
HAFN
$5.14B
| $1.11K | ﹤0.01% |
147
| – | – |
2024 Q3
6 quarters
|
|
|
TMDE
6146
TMD Energy Limited
TMDE
$15.3M
| $1.11K | ﹤0.01% |
+1,000
| New | +$1.16K |
2026 Q1
0 quarters
|
|
6147
BondBloxx CCC-Rated USD High Yield Corporate Bond ETF
XCCC
$226M
| $1.1K | ﹤0.01% |
+30
| New | +$1.12K |
2026 Q1
0 quarters
|
|
6148
Global X Genomics & Biotechnology ETF
GNOM
$106M
| $1.06K | ﹤0.01% |
24
| – | – |
2023 Q3
10 quarters
|
|
6149
Hagerty
HGTY
$1.53B
| $1.06K | ﹤0.01% |
101
-732
| -88% | -$8.55K |
2025 Q2
3 quarters
|
|
6150
Diana Shipping Inc Warrants exp 2026
DSX.WS
$14.1M
| $1.03K | ﹤0.01% |
4,687
-36
| -0.8% | -$9 |
2023 Q4
9 quarters
|
|
Similar funds
Wells Fargo's Q1 2026 Portfolio in Review
As of Q1 2026, Wells Fargo held 7,538 positions worth $530B, down 3.4% from $549B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Wells Fargo's Q1 2026 filing shows 554 new, 2,218 increased, 3,438 reduced and 458 closed positions. Its largest new stake was Sunbelt Rentals Holdings: 534,606 shares worth $34.8M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $7.91B.
By sector, the portfolio is most concentrated in Miscellaneous at 47% of assets, down from 47% a quarter earlier, followed by Technology and Financials.
- Wells Fargo's largest Q1 2026 buy was Sunbelt Rentals Holdings: 534,606 shares worth $34.8M.
- Wells Fargo added most to iShares Core MSCI Emerging Markets ETF in Q1 2026, an estimated $771M increase.
- Wells Fargo's biggest Q1 2026 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $7.91B.
- Wells Fargo fully exited CyberArk in Q1 2026, selling an estimated $78.7M.
- Wells Fargo's ten largest holdings make up 19% of its $530B portfolio in Q1 2026.
- Wells Fargo opened 554 new positions and closed 458 in Q1 2026.
- Wells Fargo's portfolio value fell 3.4% quarter-over-quarter to $530B.
Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.